Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion
Journal of Cutaneous Pathology · 2024
DOI: 10.1111/cup.14602 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Ahmed Shah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Nuclear Proteins, Skin Neoplasms, Transcription Factors, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nuclear protein in testis (NUT) carcinoma, molecularly defined by the NUTM1 gene rearrangement, is most commonly reported in young adults in the sinonasal tract, nasopharynx, or thorax. At these sites, NUT carcinoma is an extremely aggressive malignancy with dismal prognosis. Recently, five cases of primary cutaneous NUT adnexal carcinoma have been reported with BRD3 and NSD3 fusion partners. Although NUT adnexal carcinomas are shown to have metastatic potential, they may behave less aggressively than extracutaneous NUT carcinomas. We report a case of a 59‐year‐old man who underwent a biopsy of a 3‐cm plantar mass, which showed BRD4::NUTM1 fusion. The tumor was a poorly differentiated dermal neoplasm showing cytologic atypia, large vesicular nuclei with prominent nucleoli, conspicuous mitotic activity, and foci of necrosis. Immunohistochemically, the tumor showed positivity for keratins, EMA, SOX10, and NUT, with patchy smooth muscle actin. Molecular testing revealed BRD4::NUTM1 rearrangement. With no alternative primary identified by imaging, a diagnosis of primary cutaneous NUT carcinoma was favored. We hope to contribute to the limited body of knowledge on this entity, with emphasis on recognition as well as studying and defining its prognostic differences from extracutaneous NUT carcinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
- Alberta Precision Laboratories, Calgary, Alberta, Canada.
ORCID-Profile: Thomas Brenn
Zitieren
APA
Shah, A., Box, A., Brenn, T., & Flaman, A. (2024). Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14602
Vancouver
Shah A, Box A, Brenn T, Flaman A. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14602
BibTeX
@article{Shah2024,
author = {Shah, Ahmed and Box, Adrian and Brenn, Thomas and Flaman, Ashley},
title = {Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion},
journal = {Journal of Cutaneous Pathology},
year = {2024},
doi = {10.1111/cup.14602}
}
EUVIMED